Community Capital’s Garrett Smith Attends Milken Institute Global Conference
– Smith to join influential thought leaders and innovators in addressing critical global issues – NEW YORK & LOS ANGELES–(BUSINESS WIRE)–#bankinginnovation–Garrett... Read more.
New Real-World Retrospective Analysis Presented at AUA 2024 Reports 86% Recurrence-Free Survival (RFS) at 24 Months with JELMYTO® Across All Studied Patient and Disease Characteristics in Cohort of Responders to Induction Therapy
There Were No Differences in RFS Regarding Usage for Chemoablation or Post-Endoscopic Ablation, Tumor Size, Multifocality, or Tumor Location RFS Was 100% in Patients... Read more.
China’s 2024 Labor Day Sees 77% Rise in Outbound Travel Transactions and 700% Surge in Inbound Spending YoY via Alipay
Outbound travel transactions via Alipay saw a 77% increase year-on-year, with total spending up by 10%. Top destinations are Hong Kong SAR, Japan, Macao SAR, Korea,... Read more.
Smart Meter Introduces World’s First Cellular-Enabled Glucose Meter with Notifications and Multi-Language Capabilities
Innovative, Patient-Friendly Solution for the Rapidly Growing Remote Patient Monitoring and Chronic Care Management Markets TAMPA, Fla.–(BUSINESS WIRE)–Smart... Read more.
F5 Recognized as API Security Visionary by Enterprise Management Associates
SEATTLE–(BUSINESS WIRE)–F5 (NASDAQ: FFIV) announced that it has been singled out as a visionary in API security for its F5 Distributed Cloud Web App... Read more.
Pushing the Boundaries of Neuroscience with GE HealthCare’s SIGNA MAGNUS
SIGNA MAGNUSi is a high-performance head-only MR scanner from GE HealthCare that could expand the field of neuroscience, which has been limited by the performance... Read more.
BrainChip and Frontgrade Gaisler to Augment Space-Grade Microprocessors with AI Capabilities
LAGUNA HILLS, Calif. & GÖTEBORG, Sweden–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first commercial... Read more.
UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024
New and Recurrent Patients Treated with UGN-102 Achieved Similar Durability of Response Rates (DOR) at 12 months PRINCETON, N.J–(BUSINESS WIRE)–UroGen... Read more.
Teijin Automotive Technologies Celebrates Opening of Huntington, Indiana, Facility Expansion
AUBURN HILLS, Mich.–(BUSINESS WIRE)–#safety–Teijin Automotive Technologies held a ribbon cutting today to celebrate the opening of its new topcoat... Read more.
CORRECTING and REPLACING Babson Diagnostics Partners with Cynergy Wellness, Inc.
Cynergy Wellness to provide clinician oversight of BetterWay™ customer-initiated blood testing orders AUSTIN, Texas–(BUSINESS WIRE)–Please replace... Read more.